The Cannigma

APRIL 12, 2023

MoreBetter, creators of the Releaf App, is using this real world data to push back against the claim that there’s no evidence that CBN can help people sleep. In September 2021, MoreBetter hosted a self-reported data collection with this CBN tincture offered to participants for free of charge from CBDistillery. Back to our study.

Sleep 137

Sleep Data Tincture Research and Development 137

NORML

JULY 2, 2019

Adults who purchase retail cannabis typically report using it to mitigate pain and to improve sleep, and often use it in place of conventional medications, according to data published online today in the Journal of Psychoactive Drugs.

Retail 226

Retail Sleep History Medicine 226

NORML

MARCH 7, 2019

Also introduced was The Marijuana Data Collection Act of 2019 , which would study the effects of state legalized medicinal and non-medicinal marijuana programs from a variety of perspectives, including state revenues, public health, substance abuse and opioids, criminal justice, and employment.

Legislation 254

Legislation Marijuana Policy Research and Development 254

NORML

MAY 26, 2020

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain.

Clinical Trials 278

Clinical Trials Chronic Pain Cannabinoids Patients 278

NORML

MAY 23, 2019

Seniors who report the use of cannabis over the past year say that it improves their overall quality of life, according to survey data published in the journal Gerontology & Geriatric Medicine. Researchers from the University of Colorado School of Medicine surveyed 274 older respondents (mean age = 72.5

Topical 211

Topical Data Edibles Medicine 211

The Cannigma

JANUARY 16, 2021

When you walk into a hardware store, pharmacy, or even a liquor store, if you don’t know exactly what product will meet your needs there’s someone educated enough to point you to the right product and the data to back up that recommendation, says Tyler Dautrich, COO of Releaf. Edited and mixed by Michael Schaeffer Omer-Man.

Data 131

Data Research and Development Patients Strains 131

The Cannigma

NOVEMBER 24, 2022

Here’s how it works: Fill out the screening questionnaire to see if you’re a good fit Week 1: screening week for approved participants (baseline data) Weeks 2 – 3: Consuming the product and sharing your experience with People Science. The data collected will be sent to People Science, along with the responses from a short daily questionnaire.

Sleep 105

Sleep Collective Data Tincture 105

Cannabis Law Report

AUGUST 23, 2021

Medicinal Cannabis Access Data Dashboard. To improve transparency and data accessibility, the TGA publishes de-identified data on the number of unapproved medicinal cannabis products accessed through the Special Access Scheme (SAS). Here’s what they say. 19 August 2021.

Data 105

Data Access Medicine Patients 105

Cannabis Law Report

AUGUST 10, 2021

The Federal Court of Appeals in Canada ratified a Ministry of Health decision to refuse to provide J anssen Pharmaceuticals, a subsidiary of Johnson and Johnson (NYSE: JNJ ), data protection for Spravato, a ketamine analog approved for depression. What Is Data Protection And Why Is It Important? and Canada. What Happened?

Data 98

Data Pharmaceutical Treatment Medicine 98

Veriheal

MAY 30, 2023

In this article, we’ll delve into the newest research findings and explore how medicinal cannabis could revolutionize cancer pain management and reduce reliance on opioids and other medications. of the patients reported pain as their primary motivation for obtaining a medicinal cannabis prescription. Interestingly, 72.5%

Medicine 98

Medicine Treatment Patients Data 98

NORML

AUGUST 26, 2019

HB1445/SB1235, unfortunately, didn’t provide a framework for cultivating or distributing medicines, so patients had to get their cannabis from another state (a no-no under the US Department of Justice’s now-rescinded guidelines ). The certificate provides an affirmative defense for possession of those medicines.

Marijuana 244

Marijuana Legalization Programs Oil 244

Sensi Seeds

JANUARY 4, 2019

Context of the Medicinal Cannabis Situation. Since 2001, Canadians seeking to use cannabis for medical treatment have had access to it under the Marihuana Medical Access Regulations (MMAR ). Under the regulations, no intermediaries are allowed to sell medicinal cannabis to patients.

Medicine 75

Medicine Research and Development Patients Programs 75

Sensi Seeds

DECEMBER 10, 2018

They evaluate data, which is now available thanks to the efforts of the cannabis policy reform movement, and try to provide answers, especially to those who need them most, namely, medical patients. It seems as though research on cannabis and cannabinoids is taking such large strides that it even surpasses research growth in other fields.

Medicine 81

Medicine Research and Development Data Policy 81

Cannabis Law Report

JULY 20, 2021

Rahn & Associates announced today that it launched new risk management solutions for the burgeoning psychedelic medicinal industry. With our new psychedelic medicinal insurance solutions, business can access the necessary coverages to protect their business, attract qualified officers/directors, and bring new treatments to market.”.

Medicine 75

Medicine Business Research and Development Chronic Pain 75

MassRoots

MARCH 5, 2019

Cannabidiol ( CBD ), the non-psychoactive cannabinoid praised for medicinal powers like reducing the severity and frequency of seizures in children suffering from rare and otherwise untreatable forms of epilepsy, may not be the most medically beneficial molecule found in cannabis, according to new data. Data Tracking.

THC 111

THC CBD Data Cannabinoids 111

The Cannigma

MARCH 25, 2021

When the law changed in the UK in 2018, I was humbled by the efforts of those who suffer on a daily basis to achieve legal access to medicinal cannabis. Transfering nurses’ skills to cannabis medicine. The idea behind the MDT series is to place the unfamiliar cannabis medicines into a familiar case discussion format.

Patients 145

Patients Clinical Trials Medicine Events 145

Cannabis Law Report

JANUARY 23, 2020

Click on image to access THSuite website. Report: Cannabis Users’ Sensitive Data Exposed in Data Breach. Led by internet privacy researchers Noam Rotem and Ran Locar, vpnMentor’s research team discovered a data breach in THSuite, a point-of-sale system in the cannabis industry. THSuite Company Profile.

Data 59

Data Dispensary Patients Medicine 59

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Accessed July 25, 2021. Available at: [link] Accessed October 17, 2022.

CBD 144

CBD Seed-To-Sale Food Access 144

Illinois News Joint

DECEMBER 7, 2024

No data exists on how many registered medical patients are actively growing cannabis in Illinois. Though many reasons factor into the number of patients who grow and why, two trendlines that are heading in opposite direction may suggest more medical cannabis patients in Illinois are opting to grow their own medicine.

Patients 59

Patients Medicine Programs Dispensary 59

Cannabis Law Report

JULY 13, 2021

The deal with LYPHE Group means that thousands of patients will be the first in Europe to have access to pain relief delivered in a metered dose via Kanabo’s VapePod. Patients can now take their medicine without inhaling soot, tar and carcinogens into the lungs.

Extraction 105

Extraction Vaping Medicine Patients 105

The Cannigma

MAY 16, 2025

There are still medical cannabis patients going to jail and losing their homes, custody of their children, and their jobs, regardless of the market from which they purchased their medicine. So while a cannabis business can join their local chamber of commerce, a patient in hospice can be denied access to medical cannabis.

Policy 105

Policy Access Advocacy Patients 105

Illinois News Joint

OCTOBER 9, 2024

In the 144-page report, compiled by the Cannabis Regulation Oversight Office (CROO), the Department of Financial & Professional Regulation (IDFPR) states in its data summary, “Looking ahead to Fiscal Year 2025, IDFPR has already begun its efforts to further expand access to cannabis both to consumers and medical patients.

Dispensary 116

Dispensary Patients Access Legislation 116

SpeedWeed

MARCH 14, 2021

Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Through advanced data collection and the application of sophisticated algorithms, usable data is now available to help marijuana businesses: Predict trends. Met consumer demands. Reduce costs.

Data 52

Data Research and Development Marijuana Collective 52

Cannabis Law Report

AUGUST 24, 2022

Results from the third Cannabis as Medicine study. New research from the University of Sydney’s Lambert Initiative finds most Australians are still medicating with illicit cannabis, although numbers accessing prescription products have risen dramatically. 25 August 2022.

Medicine 52

Medicine Legalization Chronic Pain Access 52

The Cannigma

FEBRUARY 2, 2021

As medicinal cannabis treatments are now legal in many parts of the world, naturally, there is a growing interest in whether the products can treat neurological conditions like Parkinson’s disease. Patients can also access CBD products without a prescription through local pharmacies. Parkinson’s disease and cannabis.

Patients 111

Patients Clinical Trials Research and Development Treatment 111

Cannabis Law Report

MAY 10, 2022

More than half of all prescriptions for medicinal cannabis in Australia are written by doctors in Queensland, with prescriptions often given for conditions there is little evidence medicinal cannabis can treat, new research reveals. of prescriptions were for sleep disorders.

Medicine 52

Medicine Clinical Trials Data Sleep 52

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. The use of cannabis as a therapeutic and medicinal aid is widely supported.

Consumption 111

Consumption Patients Research and Development Data 111

Cannabis Law Report

JUNE 23, 2021

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. By 2024, the medicinal cannabis market within the United Kingdom is predicted to be worth nearly US$1.3 in real terms to £4.97 to reach 3.2

Programs 100

Programs Data Events Collective 100

Cannabis Law Report

DECEMBER 8, 2021

Access to headline, upfront, milestone and royalty data. Access to hundreds of Psychiatry deal contract documents. Comprehensive access to over 780 Psychiatry deal records. Access Psychiatry deal headline, upfront, milestone and royalty data. ARCH Personalized Medicine Initiative. Report Scope.

Access 40

Access Data Pharmaceutical Research and Development 40

Cannabis Law Report

AUGUST 10, 2021

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Cannabis Law Report

JUNE 5, 2021

” Kulfas’ presentation began with some hard data, giving an account of the importance of regulating the activity in Argentina. According to Kulfas, the benefits will include: Health rights: supply of medical cannabis to ensure better access to health. ley cáñamo argentina. .” Employment: Generation of quality jobs.

Hemp 105

Hemp Research and Development Pharmaceutical Agriculture 105

Medicinal Genomics

MARCH 27, 2019

Whole Genome Data. When it comes to sequencing your cultivar’s genetics for IP purposes, the more data the better. With more data, you can better describe your cultivar and make it harder for anyone else to claim novelty. Sequencing data is only as good as the reference to which it is compared. Publish to the Blockchain.

Data 94

Data Strains Terpenes Cultivation 94

Puff Puff Post

DECEMBER 3, 2019

The service breaks down existing barriers for patients by providing convenient access to a broader range of options through a single source, alongside expert advice and counsel from trusted healthcare professionals. Statistics Canada, accessible at [link] n1/daily-quotidien/191030/ t002a-eng.htm. TORONTO, Dec.

Access 52

Access eCommerce Wellness and Beauty Patients 52

CannaTech

SEPTEMBER 23, 2019

This commentary on the NICE UK cannabis guidelines is originally published by The Academy of Medical Cannabis , the globally leading institute for clinical training and research in cannabis-based medicinal products. Israel’s approach to cannabis has contributed to reducing stigma and increasing access for patients around the world.

Patients 79

Patients Policy Clinical Trials Research and Development 79

Cannabis Law Report

JULY 5, 2021

The ERP operates as a system, collecting data in real time and connecting it all together for your. Access Control. Since the ERP is equipped with all of the company’s information, the access to data is controlled. and each user can only access part of the information. Some users can have unique privileges to.

Pharmaceutical 111

Pharmaceutical Data Access Business 111

Veriheal

MAY 26, 2022

But one area of cannabis medicine is still lagging behind—research. RoC also works to increase patients’ access to medical cannabis by helping U.S. states pass relevant legislation and educating doctors about the power of cannabis medicine. Bringing Cannabis Into Mainstream Medicine.

Advocacy 98

Advocacy Patients Clinical Trials Education 98

Cannabis Law Report

DECEMBER 11, 2021

The UK’s first and highest-rated medical cannabis clinic, Sapphire Medical Clinics , has today announced that it is reducing the cost of its consultations and appointments for patients enrolled through the Sapphire Access Scheme. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52

Access Patients Chronic Pain Treatment 52